The role of Hippo pathway in colorectal cancer (CRC) initiation and progression has been controversial. In this issue of Cell Stem Cell, Cheung et al. (2020) shed new light on a distinct function of the transcriptional co-activator YAP as a tumor suppressor and Wnt pathway inhibitor in CRC.
Veschi V., & Stassi G. (2020). The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer. CELL STEM CELL, 27(4), 501-502 [10.1016/j.stem.2020.09.007].
Data di pubblicazione: | 2020 | |
Titolo: | The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer | |
Autori: | STASSI, Giorgio (Corresponding) | |
Citazione: | Veschi V., & Stassi G. (2020). The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer. CELL STEM CELL, 27(4), 501-502 [10.1016/j.stem.2020.09.007]. | |
Rivista: | ||
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.stem.2020.09.007 | |
Abstract: | The role of Hippo pathway in colorectal cancer (CRC) initiation and progression has been controversial. In this issue of Cell Stem Cell, Cheung et al. (2020) shed new light on a distinct function of the transcriptional co-activator YAP as a tumor suppressor and Wnt pathway inhibitor in CRC. | |
Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
The hippo show must go on.pdf | Pre-print | Administrator Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.